Opinion
The Bulwark on MSNOpinion

FDA reverses decision about Moderna flu vaccine

Andrew Egger and Jonathan Cohn give their takes on the stunning back-and-forth at the FDA over Moderna’s new mRNA flu vaccine, why the agency initially refused to even review the application, and what ...
A challenging public health policy landscape under health secretary Robert F. Kennedy has vaccine makers rethinking ...
Traditionally, vaccines protect against one particular pathogen, but in this study, Stanford Medicine researchers created a vaccine that successfully offered immunity from respiratory viruses, ...
Nine states are seeing moderate flu activity, while 26 report high or very high case rates. Flu test positivity continues to ...